EGA
BIIB icon

E&G Advisors’s Biogen BIIB Stock Holding History

E&G Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,050
Closed -$294K – 205
2021
Q1 		$294K Hold
1,050
– – 0.09% 171
2020
Q4 		$257K Hold
1,050
– – 0.08% 168
2020
Q3 		$298K Hold
1,050
– – 0.1% 143
2020
Q2 		$281K Hold
1,050
– – 0.11% 145
2020
Q1 		$332K Sell
1,050
-100
-9% -$30.3K 0.16% 111
2019
Q4 		$341K Sell
1,150
-15
-1% -$4.16K 0.13% 156
2019
Q3 		$271K Hold
1,165
– – 0.11% 162
2019
Q2 		$272K Sell
1,165
-15
-1% -$3.46K 0.12% 159
2019
Q1 		$279K Sell
1,180
-1,170
-50% -$368K 0.12% 158
2018
Q4 		$707K Buy
2,350
+400
+21% +$128K 0.32% 88
2018
Q3 		$689K Sell
1,950
-700
-26% -$241K 0.26% 101
2018
Q2 		$769K Buy
2,650
+1,100
+71% +$309K 0.32% 80
2018
Q1 		$424K Hold
1,550
– – 0.18% 122
2017
Q4 		$494K Sell
1,550
-570
-27% -$183K 0.21% 104
2017
Q3 		$664K Sell
2,120
-30
-1% -$8.88K 0.3% 72
2017
Q2 		$583K Hold
2,150
– – 0.28% 79
2017
Q1 		$588K Sell
2,150
-50
-2% -$14.1K 0.3% 78
2016
Q4 		$624K Sell
2,200
-205
-9% -$60.8K 0.37% 65
2016
Q3 		$753K Buy
2,405
+200
+9% +$59.2K 0.44% 55
2016
Q2 		$533K Hold
2,205
– – 0.32% 66
2016
Q1 		$574K Sell
2,205
-700
-24% -$185K 0.37% 56
2015
Q4 		$890K Buy
2,905
+190
+7% +$54.6K 0.53% 47
2015
Q3 		$792K Buy
2,715
+100
+4% +$33K 0.5% 51
2015
Q2 		$1.06M Buy
2,615
+140
+6% +$56.2K 0.62% 44
2015
Q1 		$1.04M Buy
2,475
+50
+2% +$19.7K 0.62% 44
2014
Q4 		$823K Buy
2,425
+15
+0.6% +$4.85K 0.53% 53
2014
Q3 		$797K Buy
+2,410
New +$795K 0.51% 61

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

E&G Advisors's BIIB Position: Q2 2021 in Review

E&G Advisors sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,050 shares — an estimated $294K sold.

E&G Advisors first reported a position in BIIB in Q3 2014 and held it in 27 quarters. The position peaked at $1.06M in Q2 2015. 1,105 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • E&G Advisors reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • E&G Advisors sold 1,050 Biogen shares in Q2 2021, an estimated $294K.
  • E&G Advisors first reported a position in Biogen in Q3 2014 and held it in 27 quarters.
  • E&G Advisors's Biogen position peaked at $1.06M in Q2 2015.
  • 1,105 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on E&G Advisors's 13F filing for Q2 2021, filed 12 Jul 2021.